New test shows promise in identifying new drugs to treat Lyme disease
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a test they say will allow them to test thousands of FDA-approved drugs to see if they will work against the bacteria that causes tick-borne Lyme disease. The researchers, reporting Nov. 3 in the journal PLOS ONE, say doctors and patients are desperate…